ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 16 filers reported holding ARRAY BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $26,041,000 | +10.7% | 14,405,000 | -17.2% | 1.27% | +11.4% |
| Q2 2017 | $23,518,000 | +40.3% | 17,405,000 | +47.8% | 1.14% | +13.7% |
| Q1 2017 | $16,760,000 | +37.4% | 11,774,000 | +34.7% | 1.00% | +50.8% |
| Q4 2016 | $12,199,000 | -4.8% | 8,744,000 | -17.1% | 0.67% | +7.4% |
| Q3 2016 | $12,816,000 | +191.0% | 10,546,000 | +103.8% | 0.62% | +110.9% |
| Q2 2016 | $4,404,000 | +149.8% | 5,175,000 | +134.7% | 0.29% | +172.2% |
| Q1 2016 | $1,763,000 | -64.4% | 2,205,000 | -57.6% | 0.11% | -63.3% |
| Q4 2015 | $4,957,000 | -11.5% | 5,205,000 | -8.8% | 0.29% | -10.6% |
| Q3 2015 | $5,598,000 | -29.8% | 5,705,000 | -9.4% | 0.33% | -11.6% |
| Q2 2015 | $7,972,000 | -6.6% | 6,300,000 | -7.4% | 0.37% | -14.3% |
| Q1 2015 | $8,532,000 | +206.1% | 6,800,000 | +126.7% | 0.43% | +214.5% |
| Q4 2014 | $2,787,000 | +217.8% | 3,000,000 | +200.0% | 0.14% | +220.9% |
| Q3 2014 | $877,000 | -12.3% | 1,000,000 | 0.0% | 0.04% | +2.4% |
| Q2 2014 | $1,000,000 | – | 1,000,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|